| Year |
Citation |
Score |
| 2020 |
Chao YC, Tran Q, Tsodikov A, Kidwell KM. Joint modeling and multiple comparisons with the best of data from a SMART with survival outcomes. Biostatistics (Oxford, England). PMID 32659784 DOI: 10.1093/Biostatistics/Kxaa025 |
0.317 |
|
| 2020 |
Heijnsdijk EAM, Gulati R, Tsodikov A, Lange JM, Mariotto AB, Vickers AJ, Carlsson SV, Etzioni R. Lifetime benefits and harms of PSA-based risk screening for prostate cancer. Journal of the National Cancer Institute. PMID 32067047 DOI: 10.1093/Jnci/Djaa001 |
0.335 |
|
| 2019 |
Suresh K, Taylor JMG, Tsodikov A. A Gaussian copula approach for dynamic prediction of survival with a longitudinal biomarker. Biostatistics (Oxford, England). PMID 31820798 DOI: 10.1093/Biostatistics/Kxz049 |
0.322 |
|
| 2019 |
Chapman CH, Caram MEV, Radhakrishnan A, Tsodikov A, Deville C, Burns J, Zaslavsky A, Chang M, Leppert JT, Hofer T, Sales AE, Hawley ST, Hollenbeck BK, Skolarus TA. Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Medicine. PMID 31691526 DOI: 10.1002/Cam4.2663 |
0.32 |
|
| 2019 |
Wang S, Tsodikov A. A Self-consistency Approach to Multinomial Logit Model with Random Effects. Journal of Statistical Planning and Inference. 140: 1939-1947. PMID 20383288 DOI: 10.1016/J.Jspi.2010.01.034 |
0.339 |
|
| 2018 |
Skolarus TA, Caram ME, Chapman CH, Smith DC, Hollenbeck BK, Hawley S, Tsodikov A, Sales A, Wittmann D, Zaslavsky A. Castration Remains Despite Decreasing Definitive Treatment of Localized Prostate Cancer in the Elderly: A Case for De-Implementation. Cancer. PMID 30192374 DOI: 10.1002/Cncr.31665 |
0.325 |
|
| 2018 |
Chapman CH, Burns J, Tsodikov A, Chang MG, Deville C, Hollenbeck B, Skolarus T. Clinical Predictors and Disparities in Surveillance PSA Utilization after Prostate Cancer Treatment International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1214 |
0.335 |
|
| 2017 |
de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, ... ... Tsodikov A, et al. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. Cancer. PMID 29211316 DOI: 10.1002/Cncr.31178 |
0.343 |
|
| 2017 |
Tran Q, Kidwell KM, Tsodikov A. A joint model of cancer incidence, metastasis, and mortality. Lifetime Data Analysis. PMID 28871363 DOI: 10.1007/S10985-017-9407-2 |
0.396 |
|
| 2017 |
Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, et al. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. Annals of Internal Medicine. PMID 28869989 DOI: 10.7326/M16-2586 |
0.331 |
|
| 2017 |
Suresh K, Taylor JMG, Spratt DE, Daignault S, Tsodikov A. Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model. Biometrical Journal. Biometrische Zeitschrift. PMID 28508545 DOI: 10.1002/Bimj.201600235 |
0.344 |
|
| 2017 |
Tsodikov A, Gulati R, de Carvalho TM, Heijnsdijk EAM, Hunter-Merrill RA, Mariotto AB, de Koning HJ, Etzioni R. Is prostate cancer different in black men? Answers from 3 natural history models. Cancer. PMID 28436011 DOI: 10.1002/Cncr.30687 |
0.337 |
|
| 2017 |
Marchenko O, Tsodikov A, Keener R, Katenka N, Kloster Thomas Y. Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials. Journal of Biopharmaceutical Statistics. 1-15. PMID 28281878 DOI: 10.1080/10543406.2017.1289950 |
0.381 |
|
| 2017 |
Rice JD, Tsodikov A. Semiparametric profile likelihood estimation for continuous outcomes with excess zeros in a random-threshold damage-resistance model. Statistics in Medicine. PMID 28192863 DOI: 10.1002/Sim.7237 |
0.342 |
|
| 2016 |
Rice JD, Tsodikov A. Semiparametric time-to-event modeling in the presence of a latent progression event. Biometrics. PMID 27556886 DOI: 10.1111/Biom.12580 |
0.356 |
|
| 2016 |
Tsodikov A. Branching Process Models of Cancer Richard Durrett Springer International Publishing, 2015, vii + 63 pages, €31.79, softcover ISBN: 978‐3‐319‐16064‐1 International Statistical Review. 84: 554-555. DOI: 10.1111/Insr.12202 |
0.316 |
|
| 2015 |
Ha J, Tsodikov A. Semiparametric estimation in the proportional hazard model accounting for a misclassified cause of failure. Biometrics. PMID 26102346 DOI: 10.1111/Biom.12338 |
0.377 |
|
| 2014 |
Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR. Expected population impacts of discontinued prostate-specific antigen screening. Cancer. 120: 3519-26. PMID 25065910 DOI: 10.1002/Cncr.28932 |
0.314 |
|
| 2014 |
Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nature Reviews. Urology. 11: 317-23. PMID 24818853 DOI: 10.1038/Nrurol.2014.91 |
0.35 |
|
| 2014 |
Hu C, Tsodikov A. Joint modeling approach for semicompeting risks data with missing nonterminal event status. Lifetime Data Analysis. 20: 563-83. PMID 24430204 DOI: 10.1007/S10985-013-9288-Y |
0.311 |
|
| 2013 |
Hu C, Tsodikov A. Semiparametric regression analysis for time-to-event marked endpoints in cancer studies. Biostatistics (Oxford, England). 15: 513-25. PMID 24379192 DOI: 10.1093/Biostatistics/Kxt056 |
0.399 |
|
| 2013 |
Lee SY, Tsodikov A. Correcting the Results of the Wrong Model: Treatment Effects under Early Detection of Cancer. Journal of Statistical Theory and Practice. 7: 421-441. PMID 24032001 DOI: 10.1080/15598608.2013.772033 |
0.405 |
|
| 2012 |
Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EA, Katcher J, Draisma G, Feuer EJ, de Koning HJ, Mariotto AB. The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer. 118: 5955-63. PMID 22605665 DOI: 10.1002/Cncr.27594 |
0.347 |
|
| 2012 |
Ha J, Tsodikov A. Isotonic estimation of survival under a misattribution of cause of death. Lifetime Data Analysis. 18: 58-79. PMID 22094534 DOI: 10.1007/S10985-011-9210-4 |
0.365 |
|
| 2011 |
Liu LX, Murray S, Tsodikov A. Multiple imputation based on restricted mean model for censored data. Statistics in Medicine. 30: 1339-50. PMID 21560139 DOI: 10.1002/Sim.4163 |
0.383 |
|
| 2011 |
Gulati R, Wever EM, Tsodikov A, Penson DF, Inoue LY, Katcher J, Lee SY, Heijnsdijk EA, Draisma G, de Koning HJ, Etzioni R. What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 740-50. PMID 21546365 DOI: 10.1158/1055-9965.Epi-10-0718 |
0.358 |
|
| 2010 |
deVere White RW, Tsodikov A, Stapp EC, Soares SE, Fujii H, Hackman RM. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutrition and Cancer. 62: 1036-43. PMID 21058191 DOI: 10.1080/01635581.2010.492085 |
0.306 |
|
| 2009 |
Chefo S, Tsodikov A. Stage-specific cancer incidence: an artificially mixed multinomial logit model. Statistics in Medicine. 28: 2054-76. PMID 19452568 DOI: 10.1002/Sim.3615 |
0.721 |
|
| 2009 |
Wang R, Morris DS, Tomlins SA, Lonigro RJ, Tsodikov A, Mehra R, Giordano TJ, Kunju LP, Lee CT, Weizer AZ, Chinnaiyan AM. Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer. Cancer Research. 69: 3810-8. PMID 19383904 DOI: 10.1158/0008-5472.Can-08-4405 |
0.327 |
|
| 2009 |
Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. Journal of the National Cancer Institute. 101: 374-83. PMID 19276453 DOI: 10.1093/Jnci/Djp001 |
0.393 |
|
| 2008 |
Tsodikov A, Chefo S. Generalized Self-Consistency: Multinomial logit model and Poisson likelihood. Journal of Statistical Planning and Inference. 138: 23802397. PMID 18709183 DOI: 10.1016/J.Jspi.2007.10.004 |
0.7 |
|
| 2008 |
Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, Demichelis F, Helgeson BE, Laxman B, Morris DS, Cao Q, Cao X, Andrén O, Fall K, Johnson L, ... ... Tsodikov A, et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell. 13: 519-28. PMID 18538735 DOI: 10.1016/J.Ccr.2008.04.016 |
0.333 |
|
| 2008 |
Gusev Y, Hanin L, Klebanov L, Tsodikov A, Yanev NM, Zorin A. Dr. Andrei Yakovlev: visionary, leader, iconoclast. Biology Direct. 3: 10. PMID 18366793 DOI: 10.1186/1745-6150-3-10 |
0.315 |
|
| 2008 |
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Cancer Research. 68: 645-649. PMID 18245462 DOI: 10.1158/0008-5472.Can-07-3224 |
0.359 |
|
| 2008 |
Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes & Control : Ccc. 19: 175-81. PMID 18027095 DOI: 10.1007/S10552-007-9083-8 |
0.365 |
|
| 2006 |
Tsodikov A, Szabo A, Wegelin J. A population model of prostate cancer incidence Statistics in Medicine. 25: 2846-2866. PMID 16397859 DOI: 10.1002/Sim.2257 |
0.376 |
|
| 2004 |
Broët P, Tsodikov A, De Rycke Y, Moreau T. Two-sample statistics for testing the equality of survival functions against improper semi-parametric accelerated failure time alternatives: an application to the analysis of a breast cancer clinical trial. Lifetime Data Analysis. 10: 103-20. PMID 15293627 DOI: 10.1023/B:Lida.0000030198.06968.98 |
0.329 |
|
| 2003 |
Tsodikov A. Semiparametric models: a generalized self-consistency approach. Journal of the Royal Statistical Society Series B-Statistical Methodology. 65: 759-774. PMID 21127741 DOI: 10.1111/1467-9868.00414 |
0.34 |
|
| 2002 |
Tsodikov A. Semi-parametric models of long- and short-term survival: an application to the analysis of breast cancer survival in Utah by age and stage. Statistics in Medicine. 21: 895-920. PMID 11870824 DOI: 10.1002/Sim.1054 |
0.372 |
|
| 2002 |
Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecologic Oncology. 84: 36-42. PMID 11748973 DOI: 10.1097/00006254-200205000-00015 |
0.31 |
|
| 2001 |
Bartoszyński R, Edler L, Hanin L, Kopp-Schneider A, Pavlova L, Tsodikov A, Zorin A, Yakovlev AY. Modeling cancer detection: Tumor size as a source of information on unobservable stages of carcinogenesis Mathematical Biosciences. 171: 113-142. PMID 11395047 DOI: 10.1016/S0025-5564(01)00058-X |
0.327 |
|
| 2001 |
Tsodikov A. Estimation of survival based on proportional hazards when cure is a possibility Mathematical and Computer Modelling. 33: 1227-1236. DOI: 10.1016/S0895-7177(00)00311-3 |
0.358 |
|
| 1999 |
von Collani E, Tsodikov A, Yakovlev A, Mayer-Proschel M, Noble M. A random walk model of oligodendrocyte generation in vitro and associated estimation problems. Mathematical Biosciences. 159: 189-204. PMID 10414033 DOI: 10.1016/S0025-5564(99)00017-6 |
0.321 |
|
| 1998 |
Tsodikov A, Müller WA. Modeling carcinogenesis under a time-changing exposure. Bellman Prize in Mathematical Biosciences. 152: 179-191. PMID 9780614 DOI: 10.1016/S0025-5564(98)10030-5 |
0.325 |
|
| 1998 |
Tsodikov A, Hasenclever D, Loeffler M. Regression with bounded outcome score: evaluation of power by bootstrap and simulation in a chronic myelogenous leukaemia clinical trial Statistics in Medicine. 17: 1909-1922. PMID 9777686 DOI: 10.1002/(Sici)1097-0258(19980915)17:17<1909::Aid-Sim890>3.0.Co;2-0 |
0.336 |
|
| 1998 |
Tsodikov A, Loeffler M, Yakovlev A. A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease. Statistics in Medicine. 17: 27-40. PMID 9463847 DOI: 10.1002/(Sici)1097-0258(19980115)17:1<27::Aid-Sim720>3.0.Co;2-Q |
0.318 |
|
| 1998 |
Tsodikov A. A proportional hazards model taking account of long-term survivors. Biometrics. 54: 1508-1516. DOI: 10.2307/2533675 |
0.334 |
|
| 1998 |
Tsodikov A. Asymptotic efficiency of a proportional hazards model with cure Statistics & Probability Letters. 39: 237-244. DOI: 10.1016/S0167-7152(98)00056-X |
0.325 |
|
| 1996 |
Ivankov A, Tsodikov A, Yakovlev A. Computer Simulation Of Tumor Recurrence Journal of Biological Systems. 4: 291-302. DOI: 10.1142/S0218339096000211 |
0.3 |
|
| Show low-probability matches. |